ÇELİK, A. O. Et Al. 2019. Serum total and bioactive fibroblast growth factor 21 levels are similar in patients with gestational diabetes mellitus and healthy pregnant controls. 21st European Congress of Endocrinology , (Lyon, France).

ÇELİK, A. O., KÜÇÜKSARAÇ KIYICI, D. S., ÜSTÜNDAĞ, Y., SIĞIRLI, D., GÜÇLÜ, M., & ÜSTÜNYURT, E., (2019). Serum total and bioactive fibroblast growth factor 21 levels are similar in patients with gestational diabetes mellitus and healthy pregnant controls . 21st European Congress of Endocrinology, Lyon, France

ÇELİK, ALİ Et Al. "Serum total and bioactive fibroblast growth factor 21 levels are similar in patients with gestational diabetes mellitus and healthy pregnant controls," 21st European Congress of Endocrinology, Lyon, France, 2019

ÇELİK, ALİ O. Et Al. "Serum total and bioactive fibroblast growth factor 21 levels are similar in patients with gestational diabetes mellitus and healthy pregnant controls." 21st European Congress of Endocrinology , Lyon, France, 2019

ÇELİK, A. O. Et Al. (2019) . "Serum total and bioactive fibroblast growth factor 21 levels are similar in patients with gestational diabetes mellitus and healthy pregnant controls." 21st European Congress of Endocrinology , Lyon, France.

@conferencepaper{conferencepaper, author={ALİ OSMAN ÇELİK Et Al. }, title={Serum total and bioactive fibroblast growth factor 21 levels are similar in patients with gestational diabetes mellitus and healthy pregnant controls}, congress name={21st European Congress of Endocrinology}, city={Lyon}, country={France}, year={2019}}